Ana Vujic

Has grant

Assistant Research Professor

University of Cambridge
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

THE ROLE OF DNA METHYLATION IN HEART FAILURE

Open Date: 2008-10-01

Close Date: 2012-10-01

Grant: Close

Mitochondrial regulation of HFpEF

Open Date:

Close Date:

Articles (5)

Aging leads to structural and functional deterioration of the heart, reducing its capacity to withstand internal and external stressors and consequently increasing the risk of heart failure. Exercise is a potent modulator of cardiovascular and metabolic health, offering numerous physiological benefits that can persist throughout the aging process. Studies suggest that exercise can decelerate age-related cardiac deterioration and mitigate the risk of heart failure. In this review, we discuss recent advances in our understanding of exercise-mediated molecular and cellular adaptations that could serve as therapeutic targets for age-related cardiac remodeling and functional decline. We also explore how exercise-induced changes may enhance cardiac resilience with age, examine sex differences in cardiac aging and response to exercise, and highlight the value of murine exercise models as research tools for identifying novel therapeutic targets and strategies to combat heart failure.

Year:

2025

Chronic kidney disease (CKD) is characterised by progressive loss of kidney function and structural damage, which contributes to systemic complications, including cardiovascular dysfunction. Inter-organ metabolic interactions are increasingly recognised as important in the pathophysiology of CKD, but the extent to which systemic bioenergetic deficits contribute to cardiac dysfunction remains unclear. We investigated cardiac and systemic metabolic remodeling in two rat models of CKD with distinct aetiologies: glomerulosclerosis induced by partial nephrectomy and interstitial fibrosis induced by an adenine-rich diet. Despite differing renal pathology, both models exhibited comparable cardiac dysfunction, including impaired recovery following 25 min of ischaemia. 1 H NMR spectroscopy metabolomic analysis revealed that systemic metabolic alterations in skeletal muscle, liver, and kidney were more pronounced than those in the heart, indicating reduced systemic bioenergetic reserve. These findings were supported by data from CKD patients, in whom 31 P NMR spectroscopy of exercising skeletal muscle demonstrated impaired phosphocreatine recovery, consistent with diminished bioenergetic capacity and reduced force generation. These results suggest that systemic bioenergetic impairment contributes to CKD-associated cardiac dysfunction. Targeting systemic metabolic derangements may represent a novel strategy to improve cardiac outcomes in CKD.

Year:

2025

Loss of reverse electron transport (RET)-reactive oxygen species (ROS) impairs diastolic function and exercise capacity, which can be improved by long-term aerobic exercise. RET-ROS may act as a modulator of cardiac metabolism.

Year:

2025

The mitochondrial metabolite succinate is a key driver of ischemia/reperfusion injury (IRI). Targeting succinate metabolism by inhibiting succinate dehydrogenase (SDH) upon reperfusion using malonate is an effective therapeutic strategy to achieve cardioprotection in the short term ( 60%) and fractional shortening (~ 30%), as well as significantly less collagen deposition than control hearts. Malonate administration upon reperfusion prevents post-MI HF. Acidification of malonate enables lower doses of malonate to also achieve long-term cardioprotection post-MI. Therefore, the administration of acidified malonate upon reperfusion is a promising therapeutic strategy to prevent IRI and post-MI HF.

Year:

2024

Year:

2023

Collaborators (9)

Esben Søvsø Szocska Hansen

Aarhus University

DENMARK
View details

Amy Wagers

Professor

Harvard University

UNITED STATES
View details

Hiran Prag

The University of Manchester

UNITED KINGDOM
View details

James Clark

Professor of Cardiovascular and Physiology Education

King’s College London

UNITED KINGDOM
View details

Martin Bennett

BHF Professor of Cardiovascular Sciences

University of Cambridge

UNITED KINGDOM
View details

Jack Miller

Associate Professor of Medical Physics and Metabolic Imaging

Aarhus University

DENMARK
View details

Dunja Aksentijevic

Professor of Cardiovascular Physiology and Metabolism

William Harvey Research Institute

UNITED KINGDOM
View details

Michael Murphy

Professor of Mitochondrial Redox Biology

University of Cambridge

UNITED KINGDOM
View details

Niels Henrik Buus

Aarhus University Hospital

DENMARK
View details